Home Page
-
Study reveals potential new way to stop a common kidney cancer
Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it. Read MoreJun. 4, 2024
-
Transformative agreements will save Vanderbilt authors beaucoup dollars in open access fees
The Jean and Alexander Heard Libraries have successfully negotiated a series of open access agreements with major scientific publishers that expand the number of journals available to Vanderbilt University researchers and enhance the potential reach and impact of their published work. The initiative covers some or all of the article processing charges that Vanderbilt corresponding authors were previously responsible for paying. Read MoreJun. 4, 2024
-
Iverson named School of Medicine Basic Sciences associate dean for faculty
Tina Iverson, Louise B. McGavock Chair and Professor of pharmacology and biochemistry, will take the role of associate dean for faculty on July 1, 2024. Read MoreJun. 4, 2024
-
STOP the GAP: New cryo-ET package aims to fill in the ‘missing wedge’
Cryo-ET suffers from the “missing wedge” problem: as samples become more tilted, their thickness at the extremes is increased and sample penetration decreases. William Wan and collaborators describe the creation of a new subtomogram averaging package called STOPGAP. Read MoreJun. 3, 2024
-
Pharmacology, VCAR prioritize diverse funding opportunities to support trainees and faculty
The Vanderbilt School of Medicine Basic Sciences’ pharmacology department and the Vanderbilt Center for Addiction Research hosted a special event on April 22 focused on the importance of funding for diverse trainees and faculty in academic settings. The speakers discussed the various grants to fund underrepresented trainees and faculty at various stages in their career. Read MoreJun. 2, 2024
-
Vanderbilt basic science alum Q&A: Sonja Fulmer
Sonja Fulmer, a graduate of Chemical and Physical Biology Program who is now the deputy director of the FDA’s Digital Health Center of Excellence, sat down with us to discuss her experience studying basic science at Vanderbilt and how it played a role in her successful career. Read MoreMay. 28, 2024
-
Osheroff wins Academy for Excellence in Education award
The Lillian B. Nanney Award for Outstanding Service to the VUSM/VUMC Community of Educators is a lifetime achievement award established to recognize an Academy for Excellence in Education faculty member who has demonstrated sustained outstanding service to the Vanderbilt community of educators. This year’s winner is Neil Osheroff, John G. Coniglio Professor of Biochemistry and professor of Medicine. Read MoreMay. 28, 2024
-
NIH grant supports effort to build expertise in genetic epidemiology research in Vietnam
V2-GENE, the Vanderbilt-Vietnam Genetic Epidemiology Training Program, will develop a team of researchers and educators to lead genetic epidemiology research of noncommunicable diseases across the lifespan in Vietnam. Read MoreMay. 28, 2024
-
Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe
By targeting a notoriously undruggable protein found in many cancers, the discovery of BI-0474 may pave the way for new cancer treatments. Shared on opnMe.com by Boehringer Ingelheim, this innovative molecule is available for global researchers to explore new research avenues. Read MoreMay. 28, 2024
-
Treatment-resistant depression linked to body mass index: study
Genetic factors are a small but significant contributor to severe depression that does not respond to standard therapy, according to researchers at Vanderbilt University Medical Center and Massachusetts General Hospital. Read MoreMay. 24, 2024